CAS 74103-06-3

Cetorolaco

Descrição:

Cetorolaco é um medicamento anti-inflamatório não esteroidal (AINE) utilizado principalmente por suas propriedades analgésicas, especialmente no manejo da dor moderada a severa. É caracterizado por sua capacidade de inibir a enzima ciclooxigenase (COX), que desempenha um papel crucial na síntese de prostaglandinas, compostos envolvidos na inflamação e sinalização da dor. Cetorolaco é frequentemente administrado por via oral, intramuscular ou intravenosa, e é conhecido por seu rápido início de ação. A substância é tipicamente utilizada em ambientes pós-operatórios ou para alívio da dor aguda, mas seu uso geralmente é limitado ao tratamento de curto prazo devido a potenciais efeitos colaterais, incluindo sangramento gastrointestinal, comprometimento renal e riscos cardiovasculares. Cetorolaco também é notável por sua potência relativamente alta em comparação com outros AINEs, tornando-o eficaz em doses mais baixas. Como com todos os medicamentos, é essencial usar Cetorolaco sob supervisão médica para mitigar riscos e monitorar efeitos adversos.

Fórmula: C₁₅H₁₃NO₃

InChI: InChI=1S/C15H13NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13/h1-7,11H,8-9H2,(H,18,19)

Chave InChI: InChIKey=OZWKMVRBQXNZKK-UHFFFAOYSA-N

SMILES: C(=O)(C=1N2C(C(C(O)=O)CC2)=CC1)C3=CC=CC=C3

Sinónimos:

• 1H-pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro-
• 5-(phenylcarbonyl)-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
• 5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
• Aagn 199584
• Acular LS
• Keromin
• Rs 37619
• Sprix
• Sukerin
• acide 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylique
• Ketorolac

Ketorolac

CAS: 74103-06-3

Fórmula: C₁₅H₁₃NO₃

Cor e Forma: Off-White Solid

Peso molecular: 255.28

Ref: 4Z-K-0313

Ketorolac

CAS: 74103-06-3

Ketorolac

Pureza: ≥98%

Peso molecular: 255.27g/mol

Ref: 54-BUP17317

Ketorolac

Produto Controlado

CAS: 74103-06-3

Fórmula: C₁₅H₁₃NO₃

Cor e Forma: Neat

Peso molecular: 255.27

Ref: 04-C14533000

Ketorolac Tromethamine

CAS: 74103-06-3, 74103-07-4

Fórmula: C₁₅H₁₃NO₃·C₄H₁₁NO₃

Pureza: >98.0%(T)(HPLC)

Cor e Forma: White to Light yellow powder to crystal

Peso molecular: 376.41

Ref: 3B-K0053

Ketorolac

CAS: 74103-06-3

Ketorolac (Acuvail) is an NSAID that blocks prostaglandin synthesis, related to heterocyclic acetic acids.

Fórmula: C₁₅H₁₃NO₃

Pureza: 99.68%

Cor e Forma: White Crystalline Or White Powder

Peso molecular: 255.27

Ref: TM-T21412

5-Benzoyl-2,3-dihydro-1h-pyrrolizine-1-carboxylic acid

CAS: 74103-06-3

5-Benzoyl-2,3-dihydro-1h-pyrrolizine-1-carboxylic acid

Fórmula: C₁₅H₁₃NO₃

Pureza: 95%

Cor e Forma: light yellow powder

Peso molecular: 255.27g/mol

Ref: 54-OR345134

rac Ketorolac

Produto Controlado

CAS: 74103-06-3

Applications Ketorolac is an analgesic; anti-inflammatory.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Etman, M., et al.: Pharm. Technol., 32, 58 (2008), Chelladurai, S., et al.: Chem. Pharm. Bull., 56, 1596 (2008), Sanderson, H., et al.: Toxicol. Lett., 187, 84 (2009),

Fórmula: C₁₅H₁₃NO₃

Cor e Forma: Off White Solid

Peso molecular: 255.27

Ref: TR-K235615

5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid

CAS: 74103-06-3

Pureza: 95.0%

Cor e Forma: Solid

Peso molecular: 255.2729949951172

Ref: 10-F242512

Ketorolac

CAS: 74103-06-3

Ketorolac is a nonsteroidal anti-inflammatory drug that acts by inhibiting the synthesis of prostaglandins. It is used to control moderate to severe pain, and for reducing postoperative, postpartum and other types of pain. Ketorolac has been shown to be effective in a variety of clinical settings, including those involving hepatic impairment and congestive heart failure. The drug has minimal toxicity and can be used at high doses without adverse effects on the liver or kidney. In addition, ketorolac does not produce significant changes in pge2 levels in experimental models or human serum when administered orally.

Fórmula: C₁₅H₁₃NO₃

Pureza: Min. 98 Area-%

Cor e Forma: Powder

Peso molecular: 255.27 g/mol

Ref: 3D-FK35139

5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid - Racemic

CAS: 74103-06-3

5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid - Racemic (5BPC) is a drug that is used for the treatment of pain. It has been shown to be safe and effective in treating postoperative pain when given by intravenous infusion or as an oral tablet. 5BPC has minimal toxicity and is metabolized primarily by the liver with a half life of 2.6 hours. The drug has been found to have pharmacokinetic properties that allow it to be used safely in patients with hepatic impairment and in those recovering from abdominal surgery. 5BPC is a prodrug that undergoes biotransformation by esterases into its active form, pyrrolizidine alkaloid (PA). PA acts as a nonsteroidal anti-inflammatory agent and inhibits prostaglandin synthesis, which leads to analgesia. This drug also has minimal drug interactions because

Fórmula: C₁₅H₁₃O₃N

Pureza: Min. 95%

Peso molecular: 255.27 g/mol

Ref: 3D-IB58062